文献速递关节外科

高风险患者:术前阿片类药物使用影响全膝关节置换术后的阿片类药物处方、续方及结局

Patients at Risk: Preoperative Opioid Use Affects Opioid Prescribing, Refills, and Outcomes After Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2018-01-16

这项回顾性研究将53例术前使用阿片类药物的患者与106例未使用阿片类药物的初次全膝关节置换术患者按1:2匹配,随访至少2年。术前阿片类药物组出院时阿片类药物处方量更少,但续方更多、持续使用阿片类药物比例更高、术后膝关节协会评分更低、麻醉下手法松解更多。术前使用曲马多的患者也具有相同的风险。

要点

  • 术前使用阿片类药物的患者全膝关节置换术后持续使用阿片类药物的比例为39%,而未使用阿片类药物的患者为4%。
  • 术前使用阿片类药物的患者麻醉下手法松解率为8%,而未使用阿片类药物的患者为1%。
  • 术前使用曲马多的患者与使用其他阿片类药物的患者具有相同的续方、持续使用、膝关节协会评分降低和麻醉下手法松解风险。

核心结论

  • 术前使用阿片类药物的患者出院时阿片类药物处方量更少,但需要更多续方,更可能持续使用阿片类药物,并且需要更多麻醉下手法松解。
  • 这些风险也见于术前使用曲马多的患者。

研究设计与样本

  • 回顾性研究,纳入53例术前使用阿片类药物的患者,按1:2匹配106例未使用阿片类药物的初次全膝关节置换术患者,随访至少2年。

主要发现

  • 出院时平均阿片类药物总处方量为1248 mg吗啡当量,范围为0至5600 mg。
  • 术前阿片类药物组出院前平均每日吗啡当量使用量高于未使用阿片类药物组(90 ± 75 mg vs 54 ± 42 mg;P = .001)。
  • 术前阿片类药物组与未使用阿片类药物组在续方次数(1.3 ± 1.6 vs 0.4 ± 0.6;P = .0001)、持续使用阿片类药物(21例[39%] vs 5例[4%],P = .0001)、术后膝关节协会评分(85 ± 11 vs 90 ± 13;P = .01)和麻醉下手法松解(4例[8%] vs 1例[1%],P = .03)方面存在差异。
  • 术前使用曲马多的患者与使用其他阿片类药物的患者具有相同的续方、持续使用阿片类药物、膝关节协会评分降低和麻醉下手法松解风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to evaluate the effect of preoperative opioid use on opioid prescriptions, refills, and clinical outcomes after total knee arthroplasty (TKA). METHODS: A retrospective review identified 53 patients on preoperative opioids who were matched 1:2 to 106 opioid-naive patients undergoing primary TKA with at least 2-year follow-up. Opioid refills, Knee Society Score (preoperative and follow-up), morphine equivalent dose (MED) prescribed, and persistent opioid use were compared between groups. RESULTS: The average total MED prescribed at discharge was 1248 mg, ranging from 0 to 5600 mg. The average daily MED used before discharge was greater in the preoperative opioid group compared to the opioid-naive group (90 ± 75 mg vs 54 ± 42 mg; P = .001). The preoperative opioid group and opioid-naive group differed in terms of refills (1.3 ± 1.6 vs 0.4 ± 0.6; P = .0001), persistent opioid use (21 [39%] vs 5 [4%], P = .0001), postoperative KSS (85 ± 11 vs 90 ± 13; P = .01), and manipulations under anesthesia (4 [8%] vs 1 [1%], P = .03). Preoperative tramadol users had the same risk of refills, persistent opioid use, reduced KSS, and manipulation under anesthesia as those taking other opioids. CONCLUSION: Preoperative opioid users were discharged with less opioids, required more refills, were more likely to remain on opioids, and required more manipulations under anesthesia than opioid-naive patients. These risks extended to preoperative tramadol users.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hernandez NM, Parry JA, Mabry TM, et al. Patients at Risk: Preoperative Opioid Use Affects Opioid Prescribing, Refills, and Outcomes After Total Knee Arthroplasty. J Arthroplasty. 2018. PMID: 29402712. doi:10.1016/j.arth.2018.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。